An Open-label, Randomized, Uncontrolled, Preliminary Clinical Study to Evaluate the Safety and Efficacy of KH902 Following Multiple Intravetreal Injection in Patients With Diabetic Macular Edema.

Trial Profile

An Open-label, Randomized, Uncontrolled, Preliminary Clinical Study to Evaluate the Safety and Efficacy of KH902 Following Multiple Intravetreal Injection in Patients With Diabetic Macular Edema.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Conbercept (Primary)
  • Indications Diabetic macular oedema
  • Focus Adverse reactions
  • Acronyms Frontier-1
  • Most Recent Events

    • 13 Apr 2012 Additional lead trial centres and investigator identified as reported by ClinicalTrials.gov.
    • 13 Apr 2012 Planned end date changed from 1 Oct 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
    • 13 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top